Home » Topics » Regulatory » Patents

Patents
RSS

Chinese scientists disclose IDO1 inhibitors

Oct. 25, 2016

Investigators patent pfDHODH inhibitors

Oct. 25, 2016

Bristol-Myers Squibb develops IDO inhibitors

Oct. 24, 2016

AbbVie describes TRPV3 receptor antagonists

Oct. 24, 2016

Rigel Pharmaceuticals discloses TGF-beta and/or GDF-8 inhibitors

Oct. 24, 2016

Merck & Co. patents BTK inhibitors

Oct. 24, 2016

Enanta Pharmaceuticals divulges anti-hepatitis B virus agents

Oct. 21, 2016

Araxes Pharma presents novel KRAS Gly12Cys mutant inhibitors

Oct. 21, 2016

Bristol-Myers Squibb identifies new AP2-associated protein kinase 1 inhibitors

Oct. 21, 2016

Merck & Co. describes novel azacarbazole derivatives

Oct. 21, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...